# Metformin for Fibromyalgia Symptoms (INFORM Trial)

> **NCT05900466** · PHASE2 · RECRUITING · sponsor: **University of Utah** · enrollment: 72 (estimated)

## Conditions studied

- Fibromyalgia Syndrome

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05900466
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05900466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05900466, "Metformin for Fibromyalgia Symptoms (INFORM Trial)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05900466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*